Hammons Terry
Known title: SVP, GC and SecretaryCIK: 0001801393
Associated companies
Transaction History
| SHC | ▲ Buy | Grant | 22,466 | $0 | 3/2/2022 | View on chart |
| SHC | ▲ Buy | Grant | 8,791 | $0 | 11/11/2021 | View on chart |
| SHC | ▲ Buy | Grant | 22,466 | $0 | 3/2/2022 | View on chart |
| SHC | ▲ Buy | Grant | 8,791 | $0 | 11/11/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SHC Downgraded to Underweight by JP Morgan, Price Target Set at $17
JP Morgan lowered its rating on Sotera Health to Underweight and issued a new price target of $17. The downgrade came after the company's recent earnings discussion, which highlighted its current operational performance. Observers also note that the stock has risen about 35% recently, raising questions about its valuation relative to the new target.
SHC Downgraded to Underweight by JP Morgan, Price Target Set at $17. JP Morgan lowered its rating on Sotera Health to Underweight and issued a new price target of $17. The downgrade came after the company's recent earnings discussion, which highlighted its current operational performance. Observers also note that the stock has risen about 35% recently, raising questions about its valuation relative to the new target.